NILEMDO

This brand name is authorized in Austria, Estonia, Croatia, Ireland, Italy, Lithuania, Poland, Turkey, United Kingdom

Active ingredients

The drug NILEMDO contains one active pharmaceutical ingredient (API):

1 Bempedoic acid UNII 1EJ6Z6Q368 - BEMPEDOIC ACID

Bempedoic acid is an adenosine triphosphate-citrate lyase (ACL) inhibitor that lowers low-density lipoprotein cholesterol (LDL-C) by inhibition of cholesterol synthesis in the liver. Read about Bempedoic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NILEMDO Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AX15		C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AX Other lipid modifying agents
Discover more medicines within C10AX15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1816051, 1816062, 1816073, 1816084, 1816095, 1816107
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 387549
Country: IT	Agenzia del Farmaco	Identifier(s): 048721017, 048721029, 048721031, 048721043, 048721056, 048721068, 048721070, 048721082, 048721094, 048721106, 048721118
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1089830, 1089831, 1089832, 1089833, 1089834, 1089835, 1091032, 1091033, 1091034, 1091035, 1091036
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100433285
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699228090799, 8699228090805, 8699228090812, 8699228090829, 8699228090836